Psychemedics Corp (PMDI) as of December 31, 2024 presents a micro-cap service business with constrained but positive book equity of $5.1 million against total assets of $8.3 million. Under a liquidation lens, recovery to equity is marginal and dependent almost entirely on liquid assets. The MFFAIS-computed cash liquidation value is negative at -$1.77 million, reflecting that liabilities at face value exceed haircut asset recoveries when cash is included. The liquid liquidation value of $0.73 million indicates a thin positive recovery only when viewed on a quick-asset basis excluding PP&E and intangibles. Cash and cash equivalents stand at $1.42 million (100% recovery), accounts receivable net at $2.5 million (90-95% recovery yields approximately $2.25-2.37 million), and prepaid/other current assets of $1.0 million (minimal recovery). PP&E net of $2.0 million ($24.2 million gross, $22.2 million accumulated depreciation) would recover 50-70%, or approximately $1.0-1.4 million, but the asset base is largely specialized laboratory equipment whose orderly liquidation value is uncertain. Capitalized software of approximately $5.9 million gross is carried net after amortization but would receive zero recovery under liquidation. Operating lease ROU assets ($844 thousand operating, $80 thousand finance) are balance-sheet fictions in liquidation; the corresponding liabilities of $876 thousand (operating) and $81 thousand (finance) remain at face value. Total liabilities of $3.19 million include $2.71 million current: accounts payable $462 thousand, accrued liabilities $1.56 million, operating lease current $452 thousand, short-term insurance note $209 thousand. The Banc of America equipment loan was fully repaid as of December 31, 2024, eliminating secured debt that was a covenant-waiver risk in prior periods. A material development since the prior 10-Q (September 30, 2024): the Company completed a going-private reverse/forward stock split transaction approved at the November 25, 2024 annual meeting, executed a stock sale to Peter Kamin's 3K Limited Partnership raising approximately $1.93 million at $2.35 per share, and repurchased fractional shares for approximately $2.56 million. Net cash position decreased by $547 thousand for the year. The Company changed auditors from BDO to Whitley Penn LLP in June 2024. A full valuation allowance of $2.66 million is maintained against net deferred tax assets, consistent with the three-year cumulative loss position. Accumulated deficit stands at $18.6 million. Treasury stock of $10.1 million (668 thousand shares) is a significant contra-equity item absorbing book value. No goodwill or identifiable intangibles separately disclosed beyond capitalized software. Filing discusses deferred tax asset valuation in MD&A but the going-private transaction's balance sheet impact (net cash reduction, share issuance proceeds, and buyback) is disclosed in the statement of equity rather than separately tagged as a single XBRL concept.
▼ Community Notes